Regulation of monoamine transporters: Role of transporter phosphorylation
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Presynaptic biogenic amine transporters mediate reuptake of released amines from the synapse, thus regulating serotonin, dopamine and norepinephrine neurotransmission. Medications utilized in the treatment of depression, attention deficit-hyperactivity disorder and other psychiatric disorders possess high affinity for amine transporters. In addition, amine transporters are targets for psychostimulants. Altered expression of biogenic amine transporters has long been implicated in several psychiatric and degenerative disorders. Therefore, appropriate regulation and maintenance of biogenic amine transporter activity is critical for the maintenance of normal amine homoeostasis. Accumulating evidence suggests that cellular protein kinases and phosphatases regulate amine transporter expression, activity, trafficking and degradation. Amine transporters are phosphoproteins that undergo dynamic control under the influence of various kinase and phosphatase activities. This review presents a brief overview of the role of amine transporter phosphorylation in the regulation of amine transport in the normal and diseased brain. Understanding the molecular mechanisms by which phosphorylation events affect amine transporter activity is essential for understanding the contribution of transporter phosphorylation to the regulation of monoamine neurotransmission and for identifying potential new targets for the treatment of various brain diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933 · cited 3×
“The norepinephrine transporter and its functional significance NET clears NE released into the synaptic cleft in a Na+/Cl− dependent manner (Iversen, 1971,1978; Pacholczyk et al., 1991; Trendelenburg, 1991; Bonisch & Bruss, 2006).”
BackgroundThe circuitry mediating cocaine-induced reinstatement of drug-seeking behavior
McFarland, K., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08655.2001 · Cited by 905
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · cited 2×
“…mechanisms regulating amine biosynthesis, amine storage, receptor sensitivity and transporter expression are interdependent (Bengel et al., 1998; Gainetdinov et al., 1999b; Rioux et al., 1999; Sora et al., 2001; Hall et al., 2002; Gainetdinov & Caron, 2003; Li et al., 2004; Adriani et al.,…”
BackgroundNew Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731 · cited 1×
“AMPH-mediated effects on DAT properties have been discussed in a previous review (Fleckenstein et al., 2007) and the reader is also referred to a very recent review of AMPH-induced reverse transport and trafficking of DAT and NET (Robertson et al., 2009).”
BackgroundMorón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594 · cited 2×
“The hNET gene polymorphismwith an Ala-457Promutation in the coding region has been identified in an individual with the autonomic disorder orthostatic intolerance (OI) (Shannon et al., 2000).”
BackgroundZhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549 · cited 2×
“(Zhu et al., 2006) TNF-α Activation: Increased 5-HT uptake, decreased Km and increased Vmax through p38 MAPK activation.”
BackgroundThe Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393 · cited 1×
“NET also effectively clears DA in brain regions (e.g. prefrontal cortex) where DAT expression is low or absent suggesting the physiological significance of NET in controlling DA transmission and DA-induced behavior (Moron et al., 2002;Madras et al., 2005; Siuta et al., 2010).”
BackgroundSutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392 · cited 2×
“Other human variants such as Gly-55Ala, Ile-425Leu, Phe-465Leu and Leu-550Val are linked to autism (Prasad et al., 2005; Sutcliffe et al., 2005).”
BackgroundRole of norepinephrine in the pathophysiology and treatment of mood disorders
Ressler, K. J., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00127-4 · Cited by 307
Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00305.2001 · Cited by 271 · cited 1×
“DA receptor function and expression is also abnormal (Gainetdinov et al., 1999a; Jones et al., 1999; Fauchey et al., 2000; Ralph et al., 2001; Ghisi et al., 2009).”
BackgroundMorón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262 · cited 4×
“(Moron et al., 2003) CaMKII Associates with DAT, facilitates N-tail DAT phosphorylation and mediates AMPH-induced DAT mediated DA efflux.”
BackgroundInfluentialSelf-citationZhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
Goodwin, J. S., Larson, G. A., Swant, J., Sen, N., Javitch, J. A., Zahniser, N. R., De Felice, L. J., & Khoshbouei, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805298200 · Cited by 203 · cited 1×
“A recent study demonstrated that METH is more potent than AMPH in inducing DATmediated DA efflux and DA efflux induced by the DAT substrate, METH as well as by AMPH is sensitive to PKC and CaMKII inhibition (Goodwin et al., 2009).”
BackgroundCarneiro, A. M. D., Cook, E. H., Murphy, D. L., & Blakely, R. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33374 · Cited by 180 · cited 1×
“…gut (Gordon & Barnes, 2003), placenta (Balkovetz et al., 1989), lung (Paczkowski et al., 1996), adrenal chromaffin cells (Schroeter et al., 1997), blood lymphocytes (Faraj et al., 1994; Gordon & Barnes, 2003) and platelets (Jayanthi et al., 2005; Carneiro & Blakely, 2006; Carneiro et al., 2008).”
BackgroundEsler, M., Jackman, G., Bobik, A., Leonard, P., Kelleher, D., Skews, H., Jennings, G., & Korner, P. (1981) · Hypertension · doi:10.1161/01.hyp.3.2.149 · Cited by 165
Br�ss, M., Kunz, J., Lingen, B., & B�nisch, H. (1993) · Human Genetics · doi:10.1007/bf00218272 · Cited by 127 · cited 1×
“2) (Brüss et al., 1993; Gelernter et al., 1993), is a 617 amino acid protein containing 12 transmembrane domains with cytoplasmic amino- and carboxy terminals.”
BackgroundJayanthi, L. D., Samuvel, D. J., Blakely, R. D., & Ramamoorthy, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009555 · Cited by 123
Self-citationMiner, L. H., Jedema, H. P., Moore, F. W., Blakely, R. D., Grace, A. A., & Sesack, S. R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4450-05.2006 · Cited by 107 · cited 1×
“NET control of NE signaling is, thus, an important homeostatic mechanism and its dysregulation by psychostimulants is thought to contribute to the behavioral and neurochemical effects of psychostimulants (Binda et al., 2006; Dipace et al., 2007) and chronic stress (Miner et al., 2006).”
BackgroundChen, R., Furman, C. A., Zhang, M., Kim, M. N., Gereau, R. W., Leitges, M., & Gnegy, M. E. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147959 · Cited by 99 · cited 2×
“(Boudanova et al., 2008; Chang et al., 2001; Chen et al., 2009; Daniels & Amara, 1999; Holton et al., 2005; Johnson et al., 2005b; Melikian & Buckley, 1999; Vaughan et al., 1997; Zhu et al., 1997) ERK1/2 Inhibition: Decreased DAT Vmax, unaltered DA Km and decreased surface DAT proteins.”
BackgroundAdriani, W., Boyer, F., Gioiosa, L., Macrì, S., Dreyer, J.-L., & Laviola, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.042 · Cited by 97 · cited 1×
“…mechanisms regulating amine biosynthesis, amine storage, receptor sensitivity and transporter expression are interdependent (Bengel et al., 1998; Gainetdinov et al., 1999b; Rioux et al., 1999; Sora et al., 2001; Hall et al., 2002; Gainetdinov & Caron, 2003; Li et al., 2004; Adriani et al., 2009).”
BackgroundPhenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension
Rumantir, M. S., Kaye, D. M., Jennings, G. L., Vaz, M., Hastings, J. A., & Esler, M. D. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.824 · Cited by 95 · cited 1×
“Altered NET function is associated with attention, mood and cardiovascular disorders (Klimek et al., 1997; Rumantir et al., 2000; Shannon et al., 2000; Hahn et al., 2005; Esler et al., 2006; Kim et al., 2006; Haenisch et al., 2008; Hahn et al., 2008).”
Background
Cited by
Amphetamine, past and present – a pharmacological and clinical perspective
Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. J. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482532 · Cited by 617
Mechanisms of dopamine transporter regulation in normal and disease states
Vaughan, R. A., & Foster, J. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.005 · Cited by 419
“DAT is regulated by multiple signaling systems, with PKC and ERK being two of the most well-characterized [8].”
Dopaminergic dynamics underlying sex-specific cocaine reward
Calipari, E. S., Juarez, B., Morel, C., Walker, D. M., Cahill, M. E., Ribeiro, E., Roman-Ortiz, C., Ramakrishnan, C., Deisseroth, K., Han, M.-H., et al. (2017) · Nature Communications · doi:10.1038/ncomms13877 · Cited by 359
The solute carrier 6 family of transporters
Bröer, S., & Gether, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01975.x · Cited by 269
Vesicular and Plasma Membrane Transporters for Neurotransmitters
Blakely, R. D., & Edwards, R. H. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005595 · Cited by 169
“ficking to and from the cell surface, a process influenced by multiple protein kinases (Ramamoorthy et al. 2011).”
Background
Metadata
- Authors
- Ramamoorthy, S., Shippenberg, T. S., & Jayanthi, L. D.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 129
- Issue
- 2
- Pages
- 220-238
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2013844154
- Cited by
- 150
- References
- 26
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.